Yabao Pharmaceutical Group Co (SHSE:600351) Cyclically Adjusted Book per Share: ¥3.95 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600351 Yabao Pharmaceutical Group Co Ltd SHSE:600351
67 GF Score
Price ¥6.56
GF Value ¥5.53
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Yabao Pharmaceutical Group Co Cyclically Adjusted Book per Share?

Yabao Pharmaceutical Group Co SHSE:600351 -3.53% 67 Cyclically Adjusted Book per Share is ¥3.95 as of Mar. 2026. GuruFocus rates SHSE:600351 with a GF Score™ of 67/100 and a GF Value™ of ¥5.53 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Yabao Pharmaceutical Group Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥4.122. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.95 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Yabao Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 2.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Yabao Pharmaceutical Group Co was 17.80% per year. The lowest was 2.90% per year. And the median was 11.15% per year.

As of today (2026-07-19), Yabao Pharmaceutical Group Co's current stock price is ¥6.56. Yabao Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥3.95. Yabao Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 1.66.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Yabao Pharmaceutical Group Co was 5.49. The lowest was 1.40. And the median was 1.90.


Yabao Pharmaceutical Group Co  (SHSE:600351) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Yabao Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.56/3.95
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Yabao Pharmaceutical Group Co was 5.49. The lowest was 1.40. And the median was 1.90.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Yabao Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms


Yabao Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Yabao Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yabao Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Yabao Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.41 3.61 3.71 3.82 3.93

Yabao Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.85 3.87 3.91 3.93 3.95

SHSE:600351 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yabao Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yabao Pharmaceutical Group Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yabao Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Yabao Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600351
67GF Score
Yabao Pharmaceutical Group Co Ltd SHSE:600351
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yabao Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yabao Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.122/116.3033*116.3033
=4.122

Current CPI (Mar. 2026) = 116.3033.

Yabao Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.419 101.400 3.922
201609 3.393 102.400 3.854
201612 3.334 102.600 3.779
201703 3.386 103.200 3.816
201706 3.451 103.100 3.893
201709 3.503 104.100 3.914
201712 3.569 104.500 3.972
201803 3.645 105.300 4.026
201806 3.653 104.900 4.050
201809 3.689 106.600 4.025
201812 3.687 106.500 4.026
201903 3.855 107.700 4.163
201906 3.685 107.700 3.979
201909 3.772 109.800 3.995
201912 3.492 111.200 3.652
202003 3.544 112.300 3.670
202006 3.551 110.400 3.741
202009 3.591 111.700 3.739
202012 3.608 111.500 3.763
202103 3.692 112.662 3.811
202106 3.687 111.769 3.837
202109 3.747 112.215 3.883
202112 3.801 113.108 3.908
202203 3.894 114.335 3.961
202206 3.852 114.558 3.911
202209 3.860 115.339 3.892
202212 3.857 115.116 3.897
202303 3.996 115.116 4.037
202306 3.934 114.558 3.994
202309 3.955 115.339 3.988
202312 3.865 114.781 3.916
202403 4.051 115.227 4.089
202406 3.995 114.781 4.048
202409 4.100 115.785 4.118
202412 4.018 114.893 4.067
202503 4.203 115.116 4.246
202506 3.999 114.907 4.048
202509 4.040 115.471 4.069
202512 4.168 115.832 4.185
202603 4.122 116.303 4.122

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥3.95 mean?
Yabao Pharmaceutical Group Co (SHSE:600351) has a Cyclically Adjusted Book per Share of ¥3.95 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Yabao Pharmaceutical Group Co and its competitors.
Is Yabao Pharmaceutical Group Co's Cyclically Adjusted Book per Share too high?
Yabao Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥3.95. Overall, Yabao Pharmaceutical Group Co has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yabao Pharmaceutical Group Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Yabao Pharmaceutical Group Co's Cyclically Adjusted Book per Share of ¥3.95 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Yabao Pharmaceutical Group Co and its competitors. Yabao Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥3.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yabao Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co (SHSE:600351) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.53, compared to a current price of ¥6.56 — trading 18.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥3.95. Yabao Pharmaceutical Group Co's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Yabao Pharmaceutical Group Co (SHSE:600351), the current Cyclically Adjusted Book per Share is ¥3.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yabao Pharmaceutical Group Co (SHSE:600351) Overvalued in 2026?

Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥6.56 is trading 18.6% above its estimated GF Value™ of ¥5.53. GuruFocus considers Yabao Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SHSE:600351:

  • Cyclically Adjusted Book per Share: ¥3.95
  • GF Value™: ¥5.53 vs. price of ¥6.56 (18.6% above fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yabao Pharmaceutical Group Co Business Description

Address No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.
67GF Score

Get the complete analysis for SHSE:600351

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.56
Price
¥5.53
GF Value